Imagion Biosystems Ltd.Imagion Biosystems Ltd.Imagion Biosystems Ltd.

Imagion Biosystems Ltd.

No trades
See on Supercharts
Market capitalization
‪1.57 M‬USD
−0.4530USD
‪−8.89 M‬USD
‪1.12 M‬USD
‪30.23 M‬
Beta (1Y)
−1.80

About Imagion Biosystems Ltd.

Headquarters
Melbourne
Founded
2016
ISIN
AU000000IBX6
FIGI
BBG00X27KBF6
Imagion Biosystems Ltd. engages in the research and development of non-radioactive and safe diagnostic imaging technology. It offers MagSense technology which does not use ionizing radiation, radioactive tracers, or strong magnetic fields; and PrecisionMRX nanoparticles, which is used for magnetic relaxometry and other biomedical applications where the magnet susceptibility of the nanoparticle can be instrumental. The company was founded by Edward R. Flynn on December 6, 2016 and is headquartered in Melbourne, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of IBXXF is 0.2560 USD — it has decreased by 73.33% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Imagion Biosystems Ltd. stocks are traded under the ticker IBXXF.
IBXXF stock is 275.00% volatile and has beta coefficient of −1.80. Check out the list of the most volatile stocks — is Imagion Biosystems Ltd. there?
Yes, you can track Imagion Biosystems Ltd. financials in yearly and quarterly reports right on TradingView.
IBXXF net income for the last quarter is ‪−3.66 M‬ USD, while the quarter before that showed ‪−5.12 M‬ USD of net income which accounts for 28.39% change. Track more Imagion Biosystems Ltd. financial stats to get the full picture.
Today Imagion Biosystems Ltd. has the market capitalization of ‪1.57 M‬, it has decreased by 2.17% over the last week.
No, IBXXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IBXXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Imagion Biosystems Ltd. stock right from TradingView charts — choose your broker and connect to your account.
IBXXF reached its all-time high on Mar 30, 2021 with the price of 40.0000 USD, and its all-time low was 0.1000 USD and was reached on Aug 30, 2021.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Imagion Biosystems Ltd. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Imagion Biosystems Ltd. stock shows the sell signal. See more of Imagion Biosystems Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Imagion Biosystems Ltd. EBITDA is ‪−7.38 M‬ USD, and current EBITDA margin is −844.20%. See more stats in Imagion Biosystems Ltd. financial statements.